Dipanjan Banchur
Latest: Page 16
LLY's New Drug Lineup Looks Promising For Investors
Eli Lilly and Company's (LLY) new drug line-up is expected to generate higher revenues and earnings. Also, LLY's robust earnings, favorable analyst estimates, and higher-than-industry profitability make it a promising...
5 Falling Stocks That Are Still Top Rated
The major stock market indexes have tumbled over fears of aggressive interest rate hikes by the Fed to control the multi-decade high inflation and an imminent recession. This market correction...
Which Stocks Should You Consider As Recession Hits Retail?
Retail companies have faced multiple headwinds of late, including multi-decade high inflation and persistent supply chain disruptions. With recession fears looming, many retail companies have lowered their guidance for the...
United States Steel Wows Investors With Projections, Should You Buy?
美国钢铁(X)reported stellar earnings in its last reported quarter. Although analysts expect its EPS to decline this year, the company is confident of reporting solid results...
3 Buy-Rated Companies That Recently Increased Their Dividends
The stock market has been facing severe unrest due to various macroeconomic and geopolitical issues. With the fears of a looming recession, investors can consider investing in stocks that offer...
Is Commercial Metals A Buy After Its Earnings Beat?
Commercial Metals Company (CMC) reported better-than-expected earnings and revenue in the last reported quarter. Although analysts expect the company's earnings and revenue to increase in fiscal 2022, will it be...
